ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,509 | -24.6% | 10,700 | 0.0% | 0.03% | -31.6% |
| Q2 2023 | $381,562 | +15.6% | 10,700 | -17.7% | 0.04% | +22.6% |
| Q1 2023 | $330,200 | -37.4% | 13,000 | 0.0% | 0.03% | -36.7% |
| Q4 2022 | $527,280 | +22.6% | 13,000 | 0.0% | 0.05% | +22.5% |
| Q3 2022 | $430,000 | -6.1% | 13,000 | 0.0% | 0.04% | +11.1% |
| Q2 2022 | $458,000 | -23.4% | 13,000 | 0.0% | 0.04% | -18.2% |
| Q1 2022 | $598,000 | -30.6% | 13,000 | 0.0% | 0.04% | -17.0% |
| Q4 2021 | $862,000 | +6.2% | 13,000 | 0.0% | 0.05% | -10.2% |
| Q3 2021 | $812,000 | -24.6% | 13,000 | 0.0% | 0.06% | -33.0% |
| Q2 2021 | $1,077,000 | +24.9% | 13,000 | 0.0% | 0.09% | +10.0% |
| Q1 2021 | $862,000 | -13.5% | 13,000 | 0.0% | 0.08% | -27.9% |
| Q4 2020 | $997,000 | – | 13,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |